Insights & Resources | Pfizer CentreOne

The path to a secure supply chain – 10 questions to ask

In this e-Book, Jim Carr, Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses the 10 key questions to ask when diversifying your API supply chain and how our team of experts can work with you to achieve this.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne, Medicine Maker

Andrew Moore, GM of Pfizer CentreOne spoke to the Medicine Maker to discuss his leadership journey, his goals for the business and his leadership advice.

Webinar | Highly Potent Oral Solids: Challenges and Considerations

In this webinar Pfizer CentreOne’s oral solids (OSD) experts discuss key consideration highly potent oral solids (HPOSD), focusing on three key challenges faced during development and manufacture.

Case Study | Why The Right Partner is Key to Successful Drug Innovation

At Pfizer CentreOne, we are proud to collaborate with pioneering companies in navigating the drug development journey to bring their innovations to market and transform the lives of patients read about how we make it happen.

Experience the Art of Science - David Farrar's story

In our latest ‘Experience the Art of Science’ series, we meet David Farrar, Technology Specialist at our Newbridge facility and a piano player.

CPhI Discover: Embedding Responsible Manufacturing Practices across the Pharmaceutical Value Chain

Pfizer CentreOne’s API & Intermediates Business Lead, Andrew Anderson and Pfizer’s Vice President, Global Environment Health & Safety, Louise Proud, took part in a webinar for CPhI Discover to discuss natural resource efficiencies & the protection of future medicines supply.

Pfizer CentreOne Newsletter June 2021 Edition

In the latest edition of our newsletter, our bold API & Intermediates campaign, ‘In Your Corner’ takes center stage on the front cover and our Global Customer Engagement Marketing Senior Manager, Jennifer Griffin, discusses the inspiration behind the campaign.

Webinar | Technology Transfer in Sterile Injectables - Three Phases Towards Success

Pfizer CentreOne’s sterile injectables experts discuss the three phases of a technology transfer on a sterile injectable project, covering how to bridge information gaps and facilitate the path to successful regulatory filing at this fundamental stage of drug development.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Sterile Injectables Supply on Demand

Demand for supplies of materials for sterile injectable production, such as glass vials, filters, and stoppers has soared, which has resulted in shortages that have impacted the manufacturing of other drug products. In addition, there have been increased quality concerns associated with these high demand materials.

De-risking API & Intermediate Supply in a Crisis

Pharmaceutical supply chains have been consistently growing in complexity for many years. For some products, their supply chains are so complex and globalized that they start in and return to Asia after circumnavigating the globe several times.